# NCPAP + Heliox as a Treatment for Infant Respiratory Distress Syndrome (RDS)

> **NCT01383850** · PHASE2 · COMPLETED · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 51 (actual)

## Conditions studied

- Respiratory Distress Syndrome
- Bronchopulmonary Dysplasia

## Interventions

- **OTHER:** NCPAP + standard air
- **OTHER:** NCPAP + Heliox

## Key facts

- **NCT ID:** NCT01383850
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2011-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01383850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01383850, "NCPAP + Heliox as a Treatment for Infant Respiratory Distress Syndrome (RDS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01383850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*